The global healthcare IT market revenue was around US$ 382.75 billion in 2022 and is estimated to reach US$ 1763 billion by 2031, growing at a compound annual growth rate (CAGR) of 18.5% during the forecast period from 2023 to 2031.
Healthcare IT (Information Technology) is a field that integrates IT with the healthcare trade to handle and preserve information about people's health and medical care, as well as information about each patient and group of patients. This mainly focuses on assisting the healthcare provider in managing patient care through the safe exchange of health information and contributes to improving patient satisfaction, treatment, and lower costs.
Market Driving Factors
The surge in the number of clinical trials propels the market growth. For instance, in October 2022, according to U.S. national library of medicine report that, Clinical Trials listed 300,000 research analyses located in all 50 states in the United States of America and over 200 other countries around the world. Therefore, this rising number of clinical trials demands the use of IT applications which offer ease to the researchers.
Increasing demand for information technology (IT) boosts market growth. This is due to the high adoption rate of digitalization tools such as telehealth, artificial intelligence, and others in healthcare organizations is on the rise. These technologies assist in enhancing the systems, ease out the workflow, and lower the inaccuracy, surge in patient results, and reduce the price of services.
Problems with data privacy and invasion hamper the market growth.
Regional Analysis
Asia Pacific dominates the market over the forecast period. This is due to rapid urbanization, an increase in disposable income, a hectic lifestyle, increasing internet penetration, and the surge in adoption of the smartphones. Furthermore, nations like India and China are showing promising growth opportunities for the key players due to the strong economic growth in the region. This is due to the increasing economic and government initiatives for digitalizing and automating the different healthcare organizations' tasks including hospitals, pharmacies, nursing homes, and other healthcare-related associations.
North America is predicted to dominates the market. This is due to numerous factors including increasing healthcare prices, patient expectations, and legislative needs. As a result, several healthcare organizations in Canada and the US have adopted healthcare IT systems to enhance their operations. Additionally, there are many healthcare organizations, insurance companies, and healthcare IT providers in the region who are working towards the adoption of healthcare IT to enhance patient care.
Segmentation Insights
The software segment dominates the market. The range of functions provided by modern technology is expanding and the requirements for these solutions will continue to grow shortly. Data management and communication are increasing day by day due to this demand for more connectivity. The increased emphasis on patient safety with the purpose to provide quality care has opened up opportunities for new software solutions in healthcare.
The services segment dominated the market. This can be attributed shift towards cloud-based services, the surged need to curtail soaring healthcare costs, the increased adoption of digital solutions across healthcare organizations, the growth in the need to lower administrative overheads of the healthcare industry, and increased requirements to improve productivity of healthcare operations contributed to boost the segment.
Prominent Companies
Segmentation Outline
The global healthcare IT market segmentation focuses on Products and services, Components, End Users, and Region.
By Product & Services
By Component
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL HEALTHCARE IT MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: HEALTHCARE IT MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL HEALTHCARE IT MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL HEALTHCARE IT MARKET, BY PRODUCT & SERVICES
5.1 OVERVIEW
5.2 HEALTHCARE PROVIDER SOLUTIONS
5.3 HEALTHCARE PAYER SOLUTIONS
5.4 HCIT OUTSOURCING SERVICES
6 GLOBAL HEALTHCARE IT MARKET, BY COMPONENT
6.1 OVERVIEW
6.2 SERVICES
6.3 SOFTWARE
6.4 HARDWARE
7 GLOBAL HEALTHCARE IT MARKET, BY END USER
7.1 OVERVIEW
7.2 HEALTHCARE PROVIDERS
7.3 HEALTHCARE PAYERS
8 GLOBAL HEALTHCARE IT MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL HEALTHCARE IT MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 CERNER
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 OPTUM
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 CHANGE HEALTHCARE
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 COGNIZANT
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 PHILIPS HEALTHCARE
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 DELL TECHNOLOGIES
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 EPIC SYSTEMS
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 GE HEALTHCARE
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 ALLSCRIPTS
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 ATHENAHEALTH
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 IBM
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 ORACLE CORPORATION
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 ECLINICALWORKS
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 INFOR
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 CONDUENT
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.16 TATA CONSULTANCY SERVICES
10.16.1 OVERVIEW
10.16.2 FINANCIAL PERFORMANCE
10.16.3 PRODUCT OUTLOOK
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.17 CONIFER HEALTH
10.17.1 OVERVIEW
10.17.2 FINANCIAL PERFORMANCE
10.17.3 PRODUCT OUTLOOK
10.17.4 KEY DEVELOPMENTS
10.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.18 WIPRO LIMITED
10.18.1 OVERVIEW
10.18.2 FINANCIAL PERFORMANCE
10.18.3 PRODUCT OUTLOOK
10.18.4 KEY DEVELOPMENTS
10.18.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.19 INOVALON
10.19.1 OVERVIEW
10.19.2 FINANCIAL PERFORMANCE
10.19.3 PRODUCT OUTLOOK
10.19.4 KEY DEVELOPMENTS
10.19.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.20 NUANCE
10.20.1 OVERVIEW
10.20.2 FINANCIAL PERFORMANCE
10.20.3 PRODUCT OUTLOOK
10.20.4 KEY DEVELOPMENTS
10.20.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.21 3M
10.21.1 OVERVIEW
10.21.2 FINANCIAL PERFORMANCE
10.21.3 PRODUCT OUTLOOK
10.21.4 KEY DEVELOPMENTS
10.21.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.22 CARESTREAM HEALTH
10.22.1 OVERVIEW
10.22.2 FINANCIAL PERFORMANCE
10.22.3 PRODUCT OUTLOOK
10.22.4 KEY DEVELOPMENTS
10.22.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.23 INTERSYSTEMS
10.23.1 OVERVIEW
10.23.2 FINANCIAL PERFORMANCE
10.23.3 PRODUCT OUTLOOK
10.23.4 KEY DEVELOPMENTS
10.23.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.24 PRACTICE FUSION
10.24.1 OVERVIEW
10.24.2 FINANCIAL PERFORMANCE
10.24.3 PRODUCT OUTLOOK
10.24.4 KEY DEVELOPMENTS
10.24.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.25 ORION HEALTH
10.25.1 OVERVIEW
10.25.2 FINANCIAL PERFORMANCE
10.25.3 PRODUCT OUTLOOK
10.25.4 KEY DEVELOPMENTS
10.25.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.26 SAS INSTITUTE
10.26.1 OVERVIEW
10.26.2 FINANCIAL PERFORMANCE
10.26.3 PRODUCT OUTLOOK
10.26.4 KEY DEVELOPMENTS
10.26.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved